Researchers develop peptide that can target tumors, deliver agents

10/27/2009 | EurekAlert!

Two University of Rhode Island researchers have developed a peptide called pHLIP that was able to locate a tumor in a mouse then deliver imaging and therapeutic agents to the cancer cells without harming surrounding healthy cells. The peptide's delivery method involves the use of a molecular nanosyringe that can deliver nanogold particles directly to the cancerous tumors. The technology has a pending patent in the U.S. and Europe.

View Full Article in:

EurekAlert!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT